SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

July 21, 2004

 

Date of Report (date of earliest event reported)

 

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of Registrant as specified in charter)

 

Delaware

 

001-15925

 

13-3893191

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

155 Franklin Road, Suite 400

Brentwood, Tennessee  37027

(Address of principal executive offices)

 

Registrant’s telephone number, including area code:  (615) 373-9600

 

 



 

ITEM 12. Results of Operations And Financial Condition.

 

The following information is being furnished pursuant to Item 12, “Results of Operations and Financial Condition.”  Consequently, it is not deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section.  It may only be incorporated by reference in another filing under the Exchange Act or Securities Act of 1933 if such subsequent filing specifically references this Form 8-K.  On July 21, 2004, Community Health Systems, Inc. (the “Company”), announced operating results for the quarter and six months ended June 30, 2004.  A copy of the related press release is attached as Exhibit 99.1 to this Form 8-K.

 

The following table sets forth selected information concerning the projected consolidated operating results of the Company for the year ending December 31, 2004.  These projections are based on the Company’s historical operating performance, current trends and other assumptions that the Company believes are reasonable at this time.

 

The following is provided as guidance to analysts and investors:

 

Year Ending December 31, 2004 Projection Range:

 

 

 

Net operating revenues (in millions)

 

$3,350 to $3,380

 

Adjusted EBITDA (in millions)

 

$504 to $512 (a)

 

Net income per share - diluted

 

$1.51 to $1.54 (b)

 

Net cash provided by operating activities

 

$310 to $320

 

Same hospitals annual admissions growth

 

1.5% to 3%

 

Weighted average diluted shares (in millions)

 

109 to 109.5 (b)

 

Acquisitions of new hospitals

 

2 to 3

 

 

 

 

 

Net Income Per Share - Diluted by Quarter:

 

 

 

3rd quarter ending September 30, 2004 (estimate)

 

$0.36 to $0.37

 

4th quarter ending December 31, 2004 (estimate)

 

$0.39 to $0.41

 

 


For Footnotes (a) and (b) see page 3.

 

The following assumptions were used in developing the guidance provided above:

 

                       Expressed as a percent of net operating revenues, provision for bad debts is projected to be approximately 10.0% to 10.5% for 2004.

 

                       Capital expenditures are as follows (in millions): 

 

 

 

Guidance
2004

 

Actual
2003

 

Equipment and renovations

 

$140 to $143

 

$105

 

Replacement hospitals

 

$13 to $14

 

$  43

 

Total

 

$153 to $157

 

$148

 

 

                       Expressed as a percent of net operating revenues, total depreciation and amortization is projected to be approximately 4.6% to 4.9% for 2004; however, this is a fixed cost and the percentages may vary as revenues varies.

 

                       Expressed as a percentage of income before income taxes, provision for income tax is projected to be approximately 39.3% to 39.8% for 2004.

 

2



 


Footnotes from page 2

 

(a)               EBITDA consists of income before interest, income taxes and depreciation and amortization.  Adjusted EBITDA is EBITDA adjusted to exclude minority interest in earnings.  We have from time to time sold minority interests in certain of our subsidiaries or acquired subsidiaries with existing minority interest ownership positions.  We believe that it is useful to present adjusted EBITDA because it excludes the portion of EBITDA attributable to these third party interests and clarifies for investors our Company’s portion of EBITDA generated by our operations.  We use adjusted EBITDA as a measure of liquidity.  We have included this measure because we believe it provides investors with additional information about our ability to incur and service debt and make capital expenditures.  Adjusted EBITDA is the key component in the determination of our compliance with some of the covenants under our senior secured credit facility, as well as to determine the interest rate and commitment fee payable under the senior secured credit facility.

 

Adjusted EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles.  It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles.  The items excluded from adjusted EBITDA are significant components in understanding and evaluating financial performance and liquidity.  Our calculation of adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.

 

The following table reconciles adjusted EBITDA, as defined, to our net cash provided by operating activities as presented in the above guidance:

 

 

2004 Projection Range

 

 

 

(in millions)

 

Adjusted EBITDA

 

$

504

 

$

512

 

Taxes and interest expense

 

(182

)

(184

)

Other non-cash expenses and net changes in operating assets and liabilities

 

(12

)

(8

)

Net cash provided by operating activities

 

$

310

 

$

320

 

 

(b)              The inclusion of the assumed conversion of convertible notes for purposes of fully diluted calculation is expected to cause a $0.05 projected decrease in the reported net income per share in 2004.  Accordingly, for purposes of providing guidance, we have assumed the conversion of the convertible notes (after tax interest savings of $8.7 million and 8.6 million shares added to the calculation of fully diluted earnings per share).

 

The projections set forth in this report constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995.  Although the Company believes that these forward-looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic and competitive uncertainties and contingencies, which are difficult or impossible to predict accurately and are beyond the control of the Company.  Accordingly, the Company cannot give any assurance that its expectations will in fact occur and cautions that actual results may differ materially from those in the forward-looking statements.  A number of factors could affect the future results of the Company or the healthcare industry generally and could cause the Company’s expected results to differ materially from those expressed in this filing.  These factors include, among other things:

 

                       general economic and business conditions, both nationally and in the regions in which we operate;

 

                       demographic changes;

 

                       existing governmental regulations and changes in, or the failure to comply with, governmental regulations;

 

                       legislative proposals for healthcare reform;

 

                       the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003, which
includes specific reimbursement changes for small urban and non-urban hospitals;

 

3



 

                       our ability, where appropriate, to enter into managed care provider arrangements and the terms of
these arrangements;

 

                       changes in inpatient or outpatient Medicare and Medicaid payment levels;

 

                       uncertainty with the Health Insurance Portability and Accountability Act of 1996 regulations;

 

                       increases in wages as a result of inflation or competition for highly technical positions and rising supply cost due to market pressure from pharmaceutical companies and new product releases;

 

                       liability and other claims asserted against us, including self-insured malpractice claims;

 

                       competition;

 

                       our ability to attract and retain qualified personnel, including physicians, nurses and other health care workers;

 

                       trends toward treatment of patients in less acute or specialty healthcare settings, including
ambulatory surgery centers or specialty hospitals;

 

                       changes in medical or other technology;

 

                       changes in generally accepted accounting principles;

 

                       the availability and terms of capital to fund additional acquisitions or replacement facilities;

 

                       our ability to successfully acquire and integrate additional hospitals; and

 

                       the other risk factors set forth in our public filings with the Securities and Exchange Commission.

 

The consolidated operating results for the quarter and six months ended June 30, 2004, are not necessarily indicative of the results that may be experienced for any future quarter or for any future fiscal year, including this fiscal year.

 

The Company cautions that the annual projections for 2004 set forth herein are given as of the date hereof based on currently available information.  The Company is not undertaking any obligations to update these projections as conditions change or other information becomes available.

 

4



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date:  July 21, 2004

COMMUNITY HEALTH SYSTEMS, INC.

 

 

 

(Registrant)

 

 

 

 

 

 

 

By:

/s/ Wayne T. Smith

 

 

 

Wayne T. Smith

 

 

 

Chairman of the Board,

 

 

 

President and Chief Executive Officer

 

 

 

(principal executive officer)

 

 

 

 

 

 

By:

/s/ W. Larry Cash

 

 

 

W. Larry Cash

 

 

 

Executive Vice President, Chief Financial Officer
and Director

 

 

(principal financial officer)

 

 

 

 

 

 

By:

/s/ T. Mark Buford

 

 

 

T. Mark Buford

 

 

 

Vice President and Corporate Controller

 

 

 

(principal accounting officer)

 

 

5



 

Index to Exhibits Filed with the Current Report on Form 8-K Dated July 21, 2004

 

Exhibit Number

 

Description

 

 

 

99.1

 

Press Release dated July 21, 2004

 

6


Exhibit Number 99.1

 

 

Investor Contact:

 

W. Larry Cash

 

 

Executive Vice President

 

 

and Chief Financial Officer

 

 

(615) 373-9600

 

COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES

SECOND QUARTER 2004 RESULTS WITH
NET OPERATING REVENUES UP 23.8%, NET INCOME UP 25.6% AND

NET INCOME PER SHARE (DILUTED) UP 23.3%


BRENTWOOD, Tenn. (July 21, 2004)   Community Health Systems, Inc. (NYSE: CYH) today announced financial and operating results for the second quarter ended June 30, 2004.

 

Net operating revenues for the second quarter ended June 30, 2004, totaled $813.7 million, a 23.8% increase compared with $657.3 million for the same period last year.  Net income increased 25.6% to $38.4 million, or $0.37 per share (diluted), on 109.0 million weighted average shares outstanding for the quarter ended June 30, 2004, compared with $30.6 million, or $0.30 per share (diluted), on 107.8 million weighted average shares outstanding for the same period last year. Refer to page 3 for “Financial Highlights.”

 

Adjusted EBITDA for the second quarter of 2004 was $121.5 million, compared with $102.7 million for the same period last year, representing a 18.2% increase.  Included in the second quarter 2004 adjusted EBITDA is approximately $0.9 million of expenses incurred in connection with the registration and offering of common stock of certain of the Company’s stockholders completed on April 19, 2004, as referenced on page 3, footnote (b).  Adjusted EBITDA is EBITDA adjusted to exclude minority interest in earnings.  The Company uses adjusted EBITDA as a measure of liquidity.  Net cash provided by operating activities for the second quarter of 2004 was $144.3 million, compared with $142.8 million for the same period last year.  Refer to page 3, Footnote (d).

 

The consolidated financial results for the second quarter ended June 30, 2004, reflect a 19.3% increase in total admissions compared with the second quarter of 2003.  This increase is attributable to the Company’s acquisition success and strong internal growth. On a same-store basis, admissions increased 3.3% and net operating revenues increased 7.0% compared with the same period last year.

 

Net operating revenues for the six months ended June 30, 2004, totaled $1.6 billion, compared with $1.3 billion for the same period last year, a 24.3% increase, again demonstrating the Company’s successful integration of acquisitions over the last several years.  Net income increased 23.4% to $79.2 million, or $0.77 per share (diluted), on 109.1 million weighted average shares outstanding, for the six months ended June 30, 2004, compared with $64.2 million, or $0.64 per share (diluted) on 107.8 million weighted average shares outstanding, for the same period last year.

 

Adjusted EBITDA for the six months ended June 30, 2004, was $246.5 million, compared with $209.3 million for the same period last year, a 17.8% increase.  Net cash provided by operating activities for the six months ended June 30, 2004, was $206.0 million, compared with $151.3 million for the same period last year, an increase of 36.2%.  Refer to page 3, footnote (e).

 

- MORE -

 



 

The consolidated financial results for the six months ended June 30, 2004, reflect an 18.5% increase in total admissions compared with the same period last year.  On a same-store basis, admissions increased 2.6% and net operating revenues increased 7.6%, compared with the same period last year.

 

“We are pleased to once again report that Community Health Systems delivered an outstanding performance for the second quarter of 2004,” commented Wayne T. Smith, chairman, president and chief executive officer of Community Health Systems, Inc.  “Our ability to continue to drive revenues and earnings and meet our operating objectives tells us we are doing the right things.  Our strong top line growth reflects our capacity to improve the level and scope of services and enhance the financial and operating performance of our hospitals.  We are very pleased with the momentum in our business and look forward to continued progress for the remainder of 2004.”

 

On July 1, 2004, the Company completed the acquisition of Galesburg Cottage Hospital (170 beds) in Galesburg, Illinois.  On June 22, 2004, the Company announced the execution of a definitive agreement to acquire Phoenixville Hospital (143 beds) in Phoenixville, Pennsylvania.

 

“Our results to date demonstrate our ability to combine our acquisition-oriented growth strategy with solid operating metrics, delivered through our standardized and centralized approach to managing our hospitals,” added Smith.  “As we continue to gain recognition in the marketplace for our proven execution, we have extended our role as an industry leader in selectively acquiring non-urban hospitals in attractive growth markets.  Our proven ability to assimilate these acquired hospitals into our system and enhance the level of healthcare services provided in their respective communities has been the key differentiator for Community Health Systems.  We look forward to continuing to deliver favorable results for our shareholders and the communities we serve, as we stay focused on our strategy. “

 

Located in the Nashville, Tennessee suburb of Brentwood, Community Health Systems is a leading operator of general acute care hospitals in non-urban communities throughout the country. Through its subsidiaries, the Company currently owns, leases or operates 73 hospitals in 22 states.  Its hospitals offer a broad range of inpatient medical and surgical services, outpatient treatment and skilled nursing care.  Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH”.

 

Community Health Systems will hold a conference call to discuss this press release on Thursday, July 22, 2004, at 10:00 a.m. Central, 11:00 a.m. Eastern.  Investors will have the opportunity to listen to a live Internet broadcast of the conference call by clicking on the Investor Relations link of the Company’s website at www.chs.net, or at www.fulldisclosures.com.  To listen to the live call, please go to the website at least fifteen minutes early to register, download, and install any necessary audio software.  For those who cannot listen to the live broadcast, a replay will be available shortly after the call and continue through August 21, 2004.  A copy of the Company’s Form 8-K (including this press release) and conference call slide show will also be available on the Company’s website at www.chs.net.

 

Statements contained in this news release regarding expected operating results, acquisition transactions and other events are forward-looking statements that involve risk and uncertainties.  Actual future events or results may differ materially from these statements.  Readers are referred to the documents filed by Community Health Systems, Inc. with the Securities and Exchange Commission, including the Company’s Registration Statement on Form S-3 (Registration Statement No. 333-112084), and Form 10-K for the year ended December 31, 2003 and Form 10-Q for the quarter ended March 31, 2004.  These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements.

 

2



 

COMMUNITY HEALTH SYSTEMS, INC.

Financial Highlights

(Unaudited)

(In thousands, except net income per share amounts)

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

Net operating revenues

 

$

813,669

 

$

657,293

 

$

1,636,045

 

$

1,316,570

 

Adjusted EBITDA (a)

 

$

121,470

(b) 

$

102,733

 

$

246,493

(b) 

$

209,307

 

Net income

 

$

38,439

 

$

30,616

 

$

79,165

 

$

64,155

 

Net income per share - basic

 

$

0.39

 

$

0.31

 

$

0.80

 

$

0.65

 

Weighted average number of shares outstanding - basic

 

98,780

 

98,256

 

98,744

 

98,314

 

Net income per share - diluted

 

$

0.37

 

$

0.30

 

$

0.77

 

$

0.64

 

Weighted average number of shares outstanding - diluted

 

108,999

(c)

107,765

(c)

109,069

(c)

107,786

(c)

Net cash provided by operating activities

 

$

144,254

(d)

$

142,781

(d)

$

205,985

(e) 

$

151,291

(e)

 


(a)          EBITDA consists of income before interest, income taxes, and depreciation and amortization.  Adjusted EBITDA is EBITDA adjusted to exclude minority interest in earnings.  We have from time to time sold minority interests in certain of our subsidiaries or acquired subsidiaries with existing minority interest ownership positions.  We believe that it is useful to present adjusted EBITDA because it excludes the portion of EBITDA attributable to these third party interests and clarifies for investors our Company’s portion of EBITDA generated by our operations.  We use adjusted EBITDA as a measure of liquidity.  We have included this measure because we believe it provides investors with additional information about our ability to incur and service debt and make capital expenditures.  Adjusted EBITDA is the key component in the determination of our compliance with some of the covenants under our senior secured credit facility, as well as to determine the interest rate and commitment fee payable under the senior secured credit facility.

 

Adjusted EBITDA is not a measurement of financial performance or liquidity under generally accepted accounting principles.  It should not be considered in isolation or as a substitute for net income, operating income, cash flows from operating, investing or financing activities, or any other measure calculated in accordance with generally accepted accounting principles.  The items excluded from adjusted EBITDA are significant components in understanding and evaluating financial performance and liquidity.  Our calculation of adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. 

 

The following table reconciles adjusted EBITDA, as defined, to our net cash provided by operating activities as derived directly from our consolidated financial statements for the three months and six months ended June 30, 2004 and 2003 (in thousands):

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Adjusted EBITDA

 

$

121,470

 

$

102,733

 

$

246,493

 

$

209,307

 

Interest expense, net

 

(18,488

)

(16,667

)

(37,260

)

(33,683

)

Provision for income taxes

 

(25,202

)

(20,412

)

(51,903

)

(42,817

)

Other non-cash expenses, net

 

402

 

143

 

(89

)

122

 

Net changes in operating assets and liabilities, net of effects of acquisitions

 

66,072

 

76,984

 

48,744

 

18,362

 

Net cash provided by operating activities

 

$

144,254

 

$

142,781

 

$

205,985

 

$

151,291

 

 

(b)         Includes approximately $0.9 million of expenses incurred in connection with the registration and offering of common stock completed on April 19, 2004.  Net income was reduced by approximately $0.6 million or $0.01 per share (diluted) as a result of these expenses.

 

(c)          Adjusted to include assumed exercise of employee stock options and assumed conversion of convertible notes.  Since the income per share impact of the conversion of the convertible notes is less than the basic income per share for both periods presented, the convertible notes are dilutive and accordingly must be included in the fully diluted calculation (after tax interest savings of $2.2 million per quarter and 8.6 million shares added to the calculation of fully diluted earnings per share).

 

(d)   The change in net cash provided by operating activities between the three months ended June 30, 2004, and the same period in 2003 is an increase of 1.0%.  Net cash provided by operating activities for the three months ended June 30, 2003, included approximately $10 million due to the receipt of a cash advance from the Company’s Medicare Intermediary related to an anticipated payment delay resulting from a scheduled July system conversion.  Had net cash provided by operating activities for the prior year not included this cash advance, the change between periods would have been an increase of approximately 8.6%.

 

(e)          The change in net cash provided by operating activities between the six months ended June 30, 2004, and the same period in 2003 is an increase of 36.2%.  The cash advance mentioned in footnote(d) substantially offsets the build-up of accounts receivable related to acquisitions for the six months ended June 30, 2003.  Had net cash provided by operating activities for the prior year period been adjusted for both the cash advance and build-up of accounts receivable, the change between periods would have been an increase of approximately 32%.

 

3



 

COMMUNITY HEALTH SYSTEMS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

(In thousands, except net income per share amounts)

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

Net operating revenues

 

$

813,669

 

$

657,293

 

$

1,636,045

 

$

1,316,570

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Salaries and benefits

 

327,403

 

263,307

 

657,831

 

532,079

 

Provision for bad debts

 

81,721

 

62,078

 

167,832

 

124,419

 

Supplies

 

96,645

 

76,152

 

196,037

 

152,972

 

Other operating expenses

 

186,430

 

153,023

 

367,852

 

297,793

 

Depreciation and amortization

 

38,706

 

34,358

 

77,157

 

67,600

 

Minority interests in earnings

 

635

 

680

 

1,008

 

1,052

 

Total expenses

 

731,540

 

589,598

 

1,467,717

 

1,175,915

 

Income from operations

 

82,129

 

67,695

 

168,328

 

140,655

 

Interest expense, net

 

18,488

 

16,667

 

37,260

 

33,683

 

Income before income taxes

 

63,641

 

51,028

 

131,068

 

106,972

 

Provision for income taxes

 

25,202

 

20,412

 

51,903

 

42,817

 

Net income

 

$

38,439

 

$

30,616

 

$

79,165

 

$

64,155

 

Net income per share - basic

 

$

0.39

 

$

0.31

 

$

0.80

 

$

0.65

 

Net income per share - diluted

 

$

0.37

 

$

0.30

 

$

0.77

 

$

0.64

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

98,780

 

98,256

 

98,744

 

98,314

 

Diluted

 

108,999

 

107,765

 

109,069

 

107,786

 

Net income per share calculation:

 

 

 

 

 

 

 

 

 

Net income

 

$

38,439

 

$

30,616

 

$

79,165

 

$

64,155

 

Add - Convertible notes interest, net of taxes

 

2,189

 

2,189

 

4,378

 

4,378

 

Adjusted net income

 

$

40,628

 

$

32,805

 

$

83,543

 

$

68,533

 

Weighted average number of shares outstanding - basic

 

98,780

 

98,256

 

98,744

 

98,314

 

Add effect of dilutive securities:

 

 

 

 

 

 

 

 

 

Unvested common shares

 

31

 

117

 

31

 

117

 

Employee stock options

 

1,606

 

810

 

1,712

 

773

 

Convertible notes

 

8,582

 

8,582

 

8,582

 

8,582

 

Weighted average number of shares outstanding - diluted

 

108,999

 

107,765

 

109,069

 

107,786

 

Net income per share - diluted

 

$

0.37

 

$

0.30

 

$

0.77

 

$

0.64

 

 

4



 

COMMUNITY HEALTH SYSTEMS, INC.

Selected Operating Data

(Unaudited)

($ in thousands)

 

 

 

For the Three Months Ended June 30,

 

 

 

Consolidated

 

Same-Store

 

 

 

2004

 

2003

 

% Change

 

2004

 

2003

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of hospitals

 

72

 

70

 

 

 

69

 

69

 

 

 

Licensed beds

 

7,810

 

6,962

 

 

 

6,854

 

6,899

 

 

 

Beds in service

 

6,241

 

5,390

 

 

 

5,417

 

5,355

 

 

 

Admissions

 

69,145

 

57,979

 

19.3

%

59,634

 

57,744

 

3.3

%

Adjusted admissions

 

128,265

 

107,096

 

19.8

%

110,501

 

106,692

 

3.6

%

Patient days

 

279,830

 

221,735

 

26.2

%

234,899

 

220,904

 

6.3

%

Average length of stay (days)

 

4.0

 

3.8

 

5.3

%

3.9

 

3.8

 

 

 

Occupancy rate (average beds in service)

 

49.4

%

45.2

%

 

 

47.7

%

45.3

%

 

 

Net operating revenues

 

$

813,669

 

$

657,293

 

23.8

%

$

699,998

 

$

654,099

 

7.0

%

Net inpatient revenue as a % of total net operating revenues

 

50.4

%

50.2

%

 

 

49.8

%

50.2

%

 

 

Net outpatient revenue as a % of total net operating revenues

 

48.4

%

48.5

%

 

 

49.1

%

48.5

%

 

 

Income from operations

 

$

82,129

 

$

67,695

 

21.3

%

$

76,538

 

$

67,937

 

12.7

%

Income from operations as a % of net operating revenues

 

10.1

%

10.3

%

 

 

10.9

%

10.3

%

 

 

Depreciation and amortization

 

$

38,706

 

$

34,358

 

 

 

$

33,821

 

$

34,153

 

 

 

Minority interest in earnings

 

$

635

 

$

680

 

 

 

$

635

 

$

680

 

 

 

Liquidity Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

121,470

 

$

102,733

 

18.2

%

 

 

 

 

 

 

Adjusted EBITDA as a % of net operating revenues

 

14.9

%

15.6

%

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

144,254

 

$

142,781

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities as a % of net operating revenue

 

17.7

%

21.7

%

 

 

 

 

 

 

 

 

 

5



 

COMMUNITY HEALTH SYSTEMS, INC.

Selected Operating Data

(Unaudited)

($ in thousands)

 

 

 

For the Six Months Ended June 30,

 

 

 

Consolidated

 

Same-Store

 

 

 

2004

 

2003

 

% Change

 

2004

 

2003

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of hospitals

 

72

 

70

 

 

 

69

 

69

 

 

 

Licensed beds

 

7,810

 

6,962

 

 

 

6,854

 

6,899

 

 

 

Beds in service

 

6,241

 

5,390

 

 

 

5,438

 

5,351

 

 

 

Admissions

 

141,778

 

119,627

 

18.5

%

122,236

 

119,173

 

2.6

%

Adjusted admissions

 

259,280

 

217,916

 

19.0

%

223,218

 

217,112

 

2.8

%

Patient days

 

580,487

 

466,987

 

24.3

%

487,533

 

465,292

 

4.8

%

Average length of stay (days)

 

4.1

 

3.9

 

 

 

4.0

 

3.9

 

 

 

Occupancy rate (average beds in service)

 

51.4

%

47.9

%

 

 

49.6

%

48.0

%

 

 

Net operating revenues

 

$

1,636,045

 

$

1,316,570

 

24.3

%

$

1,408,906

 

$

1,309,372

 

7.6

%

Net inpatient revenue as a % of total net operating revenues

 

50.8

%

51.6

%

 

 

50.8

%

51.6

%

 

 

Net outpatient revenue as a % of total net operating revenues

 

47.8

%

47.1

%

 

 

48.0

%

47.2

%

 

 

Income from operations

 

$

168,328

 

$

140,655

 

19.7

%

$

155,283

 

$

140,543

 

10.5

%

Income from operations as a % of net operating revenues

 

10.3

%

10.7

%

 

 

11.0

%

10.7

%

 

 

Depreciation and amortization

 

$

77,157

 

$

67,600

 

 

 

$

67,794

 

$

67,194

 

 

 

Minority interest in earnings

 

$

1,008

 

$

1,052

 

 

 

$

1,008

 

$

1,052

 

 

 

Liquidity Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

246,493

 

$

209,307

 

17.8

%

 

 

 

 

 

 

Adjusted EBITDA as a % of net operating revenues

 

15.1

%

15.9

%

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

205,985

 

$

151,291

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities as a % of net operating revenue

 

12.6

%

11.5

%

 

 

 

 

 

 

 

 

 

6



 

COMMUNITY HEALTH SYSTEMS, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

($ in thousands)

 

 

 

June 30,
2004

 

December 31,
2003

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

18,605

 

$

16,331

 

Patient accounts receivable, net

 

552,378

 

559,097

 

Other current assets

 

131,189

 

120,652

 

Total current assets

 

702,172

 

696,080

 

 

 

 

 

 

 

Property and equipment

 

1,840,099

 

1,772,461

 

Less accumulated depreciation and amortization

 

(432,043

)

(377,116

)

Property and equipment, net

 

1,408,056

 

1,395,345

 

Goodwill, net

 

1,158,551

 

1,155,797

 

Other assets, net

 

112,485

 

102,989

 

 

 

 

 

 

 

Total assets

 

$

3,381,264

 

$

3,350,211

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Current maturities of long-term debt

 

$

20,132

 

$

29,677

 

Accounts payable and accrued liabilities

 

386,712

 

368,387

 

Total current liabilities

 

406,844

 

398,064

 

 

 

 

 

 

 

Long-term debt

 

1,353,782

 

1,444,981

 

Other long-term liabilities

 

175,537

 

156,577

 

Stockholders’ equity

 

1,445,101

 

1,350,589

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

3,381,264

 

$

3,350,211

 

 

7



 

COMMUNITY HEALTH SYSTEMS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

($ in thousands)

 

 

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

Cash flows from operating activities

 

 

 

 

 

Net Income

 

$

79,165

 

$

64,155

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

77,157

 

67,600

 

Minority interest in earnings

 

1,008

 

1,052

 

Other non-cash expenses, net

 

(89

)

122

 

Net changes in operating assets and liabilities, net of effects of acquisitions

 

48,744

 

18,362

 

Net cash provided by operating activities

 

205,985

 

151,291

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Acquisitions of facilities and other related equipment

 

(5,290

)

(157,176

)

Purchases of property and equipment, net

 

(82,167

)

(66,101

)

Increase in other assets

 

(14,852

)

(13,640

)

Net cash used in investing activities

 

(102,309

)

(236,917

)

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Proceeds from exercise of stock options

 

1,902

 

768

 

Stock buy-back

 

 

(12,533

)

Redemption of minority investments in joint ventures

 

(1,945

)

(115

)

Distribution to minority investors in joint ventures

 

(616

)

(1,539

)

Borrowing under credit agreement

 

45,640

 

80,000

 

Repayments of long-term indebtedness

 

(146,383

)

(88,493

)

Net cash used in financing activities

 

(101,402

)

(21,912

)

 

 

 

 

 

 

Net change in cash and cash equivalents

 

2,274

 

(107,538

)

Cash and cash equivalents at beginning of period

 

16,331

 

132,844

 

Cash and cash equivalents at end of period

 

$

18,605

 

$

25,306

 

 

- END -

 

8